Overview
Watchlist
Equities
Crypto
Soon
Popular
Home
Equities
RGC
Fundamentals

Regencell Bioscience Holdings Ltd

RGC

Chart
Fundamentals
Soon
Sentiment
Soon
Options

Revenue

0.00
0.000.00%
-

Assets

8.44M
▼-4.18M▼-33.15%
12 Months Change

Liabilities

219.51k
▼-412.81k▼-65.28%
12 Months Change

Free Cash Flow

-4.01M
▲983.28k▲19.70%
12 Months Change

Revenue/Cost Of Revenue

Net Profit/Loss

Assets/Liabilities

Cash Flows

Earnings Per Share

Outstanding Shares

Recent Quarterly and Annual Filings

2024-10-25
Form 20-F
ID: 0001213900-24-090791
2023-10-27
Form 20-F
ID: 0001013762-23-007289
2022-10-31
Form 20-F
ID: 0001213900-22-067683
2021-10-29
Form 20-F
ID: 0001213900-21-055256